Abstract:Developing photothermal agents (PTAs) for tumor therapy has three prerequisites: selectively targeting tumors, efficiently converting near‐infrared (NIR) photoenergy to heat, and degrading after the cure. These make up a combination rarely found in one material. Here a metal‐acid treatment is reported to hydrogenate metal oxide, bestowing the produced HxMoO3 with metal‐like electronic structure which enables harvesting NIR‐II light (1000−1350 nm wavelength). Importantly, created by putting acid protons into oxide, the HxMoO3 nanomaterial can resist attacking from protons in acids but is vulnerable to hydroxyl ions in alkaline. After entering biological organism, HxMoO3 PTAs persist long in acidic tumor microenvironment (TME, extracellular pH 6.5–6.9) while degrade quickly under the normal physiological environment (pH 7.2−7.4), naturally causing tumor‐selective accumulation. Under 1064 nm NIR‐II illumination, the HxMoO3 achieves a high photothermal conversion efficiency of 60.9%, leading to a high tumor inhibition rate of ≈97.25%. Such a novel PTAs integrates merits of metal and oxide, opening a door of smart photothermal therapy with self‐adaptive tumor‐accumulation and automatic degradation after tumor hyperthermia. Hydrogenated metal oxides are prepared by metal‐acid treatment, resulting in pH‐selective materials that are stable in acids but vulnerable in alkaline solutions. It led to a novel type of smart photothermal agents that target only onto tumors with acidic condition and degrade in healthy cells. They not only retain the good biocompatibility and low cytotoxicity of their parent oxide material, but also combine merits of metals with highly efficient photothermal conversion and thermal conductivity, serving as excellent photothermal reagents working in the near infrared‐Ⅱ biowindow.

Hydrophilic Molybdenum Oxide Nanomaterials with Controlled Morphology and Strong Plasmonic Absorption for Photothermal Ablation of Cancer Cells

Morphology‐controlled Synthesis of Molybdenum Oxide with Tunable Plasmon Absorption for Phothermal Therapy of Cancer

One-pot synthesis of PEGylated plasmonic MoO(3-x) hollow nanospheres for photoacoustic imaging guided chemo-photothermal combinational therapy of cancer.

Metallic oxide nanocrystals with near-infrared plasmon resonance for efficient, stable and biocompatible photothermal cancer therapy

Confined Structure Regulations of Molybdenum Oxides for Efficient Tumor Photothermal Therapy

Polyethylene Glycol–modified Molybdenum Oxide As NIR Photothermal Agent and Its Ablation Ability for HeLa Cells

Gold Nanoparticles supported on MoS2 Nanoribbons matrix as a biocompatible and water dispersible platform for enhanced photothermal ablation of cancerous cells using harmless near infrared irradiation

Molybdenum Diphosphide Nanorods with Laser‐Potentiated Peroxidase Catalytic/Mild‐Photothermal Therapy of Oral Cancer

Combinatorial discovery of Mo-based polyoxometalate clusters for tumor photothermal therapy and normal cell protection

Biomimetic layered molybdenum oxide nanosheets with excellent photothermal property combined with chemotherapy for enhancing anti-tumor immunity

Plasmonic MoO3-x Nanoparticles Incorporated in Prussian Blue Frameworks Exhibit Highly Efficient Dual Photothermal/photodynamic Therapy.

A molybdenum oxide-based degradable nanosheet for combined chemo-photothermal therapy to improve tumor immunosuppression and suppress distant tumors and lung metastases

Biocompatible PEGylated MoS2 Nanosheets: Controllable Bottom-Up Synthesis and Highly Efficient Photothermal Regression of Tumor.

Acid-Sensitive Nanoparticles Based on Molybdenum Disulfide for Photothermal-Chemo Therapy

Phase and morphological control of MoO 3-x nanostructures for efficient cancer theragnosis therapy.

pH-Activated Ce-Doped Molybdenum Oxide Nanoclusters for Tumor Microenvironment Responsive Photothermal and Chemodynamic Therapy

A Synergistic Chemodynamic-Photodynamic-Photothermal Therapy Platform Based on Biodegradable Ce-doped MoOx Nanoparticles

A PdMo Bimetallene with Precise Wavelength Adjustment and Catalysis for Synergistic Photothermal Ablation and Hydrogen Therapy of Cancer at Different Depths.

Biosafety, Nontoxic Nanoparticles for VL–NIR Photothermal Therapy Against Oral Squamous Cell Carcinoma

Hydrogenated Oxide Material for Self‐Targeting and Automatic‐Degrading Photothermal Tumor Therapy in the NIR‐II Bio‐Window

Exploring the potential of carbon-coated MoSe 2 nanoparticles as a photothermal therapy for ovarian cancer